Anebulo Pharmaceuticals, Inc.
NASDAQ:ANEB
1.895 (USD) • At close October 29, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||||||
| Nettowinst
| -1.35 | -1.654 | -2.717 | -2.481 | -2.496 | -2.798 | -3.827 | -2.612 | -2.323 | -1.876 | -1.073 | -1.553 | -29.112 | -0.556 | -0.329 | -0.256 |
| Afschrijvingen & Amortisatie
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0.177 | 0 | 0 | 0 | 0 | 0 | 0 | 0.212 | 0.227 | 0.125 | 0.094 | 0.034 | 0.115 | 0.047 | 0.021 | 0.016 |
| Verandering in Werkkapitaal
| -0.94 | -0.055 | 0.653 | -0.457 | -0.577 | 0.384 | 0.992 | 0.366 | 0.097 | 0.29 | -0.22 | 0.741 | -0.735 | -0.705 | -0.106 | 0.101 |
| Vorderingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Voorraden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Crediteuren
| -0.228 | 0.066 | -0.247 | 0.031 | -0.036 | 0.224 | 0.072 | -0.106 | 0.298 | 0.04 | -0.451 | 0.384 | 0.028 | -0.002 | -0.082 | 0.166 |
| Overig Werkkapitaal
| -0.711 | -0.121 | 0.9 | -0.031 | -0.541 | 0.159 | 0.92 | 0 | -0.201 | 0.25 | 0.231 | 0.358 | -0.763 | -0.703 | -0.024 | -0.065 |
| Overige Niet-Contante Posten
| 0.06 | 0.145 | 0.032 | 0.179 | 0.26 | -0.001 | 0.154 | -0 | -0.071 | 0.085 | 0.545 | -0.35 | 26.627 | -0.008 | 0.004 | 0.004 |
| Kasstroom uit Operationele Activiteiten
| -2.053 | -1.497 | -1.814 | -2.727 | -2.849 | -2.191 | -2.609 | -2.034 | -1.999 | -1.461 | -1.199 | -0.778 | -3.105 | -1.222 | -0.41 | -0.135 |
| Investeringsactiviteiten: | ||||||||||||||||
| Investeringen in Materiële Vaste Activa
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Overnames
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kasstroom uit Investeringsactiviteiten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financieringsactiviteiten: | ||||||||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 0 | 0 | -0.062 | 0 | -0.068 | 0 | -0.249 | 6.647 | 0 | 0 | 0 | 0 | 19.783 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8.208 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 0 | 0 | -0 | 0 | -0.068 | 0 | -0 | 0.007 | 0 | 0 | 0 | 0 | 19.783 | 0.002 | 0 | 0 |
| Kasstroom uit Financieringsactiviteiten
| 0 | 0 | -0.062 | 0 | -0.068 | 0 | -0.249 | 6.699 | 0 | 0 | 0 | 0 | 19.783 | 0.002 | 0 | 0 |
| Overige Informatie: | ||||||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -2.053 | -1.497 | -1.876 | -2.727 | -2.917 | -2.191 | -2.858 | 4.665 | -1.999 | -1.461 | -1.199 | -0.778 | 16.679 | 0.827 | -0.41 | -0.135 |
| Kaspositie aan het Einde van de Periode
| 3.094 | 5.147 | 6.645 | 8.521 | 11.247 | 14.165 | 16.355 | 19.214 | 14.548 | 16.548 | 18.009 | 19.208 | 19.986 | 3.307 | 2.48 | 2.89 |